利用创新科技,创造更有价值的燕窝滋补品 | Using Innovative Technology to Create More Valuable Bird’s Nest Products


Fuciphagus Biotechnology Sdn Bhd
Fuciphagus is one of the first Malaysian bird’s nest exporters to be approved by China
I am Moh Chee Hong, Director, and CEO of Fuciphagus Agritech Sdn Bhd.
I founded Fuciphagus in 2006, focusing on both retail and swiftlet farming, and in 2011, we transformed into a bird’s nest cleaning plant. During that same year, we were actively preparing to apply for the required qualifications to export to China. After much effort, Fuciphagus finally became one of the first Malaysian bird’s nest exporters to be approved by China in 2014.
Fuciphagus launched a public fundraising campaign to gain brand awareness, raise funds and expand its customer base, and pass on the heritage of the thousand-year-old bird’s nest culture and educate the public on the correct nutritional value of bird’s nest for safe consumption. In the long run, we are actively promoting the bird’s nest industry to research more scientific clinical studies and proofs to further categorize bird’s nest products as a nourishment category and a pharmaceutical category.
Patented 3D Biotic Materials Nano Processing Technology in US and China
Some people may not be very familiar with Fuciphagus. Our business is not limited to bird’s nest cleaning plants. Unlike our peers and competitors, we have invested the most in technological research such as Enzymatic Cleaning, Product Traceability Application System, Bird’s Nest Authentication Systems, Non-Destructive NO2 Testing Kits and various related technologies.
Application of the new automated processing technologies have completely revolutionized the traditional edible bird’s nest processing industry.
- Firstly, the automated processing technology can achieve higher yields, lower costs and better scalability.
- Secondly, the technology enable standardization of raw materials, which make a better quality standardized edible bird’s nest products.
In conclusion, we have developed an automated production system using biotechnology to achieve stable, consistent, and reproducible production of freshly bird’s nests, with longer streaks, no black spots, no tiny feathers, and 100% safe for consumption. All these can be readily presented in the test results, which we consider as an essential requirement. Still, unfortunately not all bird’s nest manufacturers or brands can achieve this standard.
At present, we mainly supply to B2B markets for export and our in-house brands in China —Yan Yu Jia Ren and Yan Wo Wang, freshly brewed bird’s nest, which is mainly for the Malaysian online market. We are looking forward to exporting some of our products to Singapore, Taiwan, Japan, and Korea in November this year. Besides, we also provide OEM service for other brands of ready-to-eat bird’s nests.
We are pleased to announce that our technical invention was patented in the US and China during August and September last year. Hence, we have to use our existing technology to rapidly increase and capture more than 50% of the market share through various promotion and marketing channels, converting the previously invested resources into profitability.
The ultimate goal is to classify bird’s nest registered as a health supplements and pharmaceutical product
Fuciphagus’ vision is to become a world-class supplier of bird’s nests with advanced technology and scientific proof within 5 years. Also, having the mission to revolutionize tradition and embrace new technology so that everyone can enjoy great nutritious bird’s nest with peace of mind.
Traditionally, bird’s nest products are classified merely as food products. Still, we are committed to applying modern science to explore bird’s nest’s nutritional value and promote the healthiest way to consume bird’s nest based on scientific findings.
The only way to show consumers the actual value of a bird’s nest is to obtain certification and recognition of its nutritional value. At the same time, it will lead the whole industry and market to a healthy, professional, and scientific path.
For example, the sialic acid content in a bird’s nest has been scientifically proven beneficial to the neutrophilic and immune systems. It may have anti-disease effects on Alzheimer’s and Parkinson’s disease. Therefore, our goal is to upgrade our bird’s nest products and have them registered under health supplements products.
Concurrent Marketing and Efficacy Certification to Enhance Product Credibility
There are many bird’s nest products worldwide, including Malaysia, which only have product verification but not efficacy certification. Efficacy certification is a difficult, costly, and time-consuming process; for instance, the most fundamental process is to standardize the raw materials.
Since Fuciphagus has mastered this technology, standardization is not a problem, which is crucial in our ability to do simultaneous marketing and clinical trials for efficacy certification. As long as the crowdfunding is successful, Fuciphagus’ clinical trial with a local university research team could begin work in the fourth quarter of this year.
At the same time, we will continue to work on developing our bird’s nest product range, segmenting the product categories, and pushing for a larger market, such as the elderly, pregnant women and children, etc. This includes integrating bird’s nests with other health products to increase its efficacy and value.
China’s bird’s nest market is up to RMB 30 billion
Malaysia’s bird’s nest exports have 23 times potential growth
Most importantly, once our bird’s nest is certified and classified as a health supplement product, we can advance from a bird’s nest market of over RM50 million per year in Malaysia to a health supplement market of over RM3.1 billion.
The market for bird’s nests is undoubtedly not limited to the country’s RM10 million market. According to the Chinese Academy of Inspection and Quarantine in the “Bird’s Nest Traceability Report 2020,” China’s import of bird’s nests from Malaysia grew from 3.09 tons in 2014 to 69.7 tons in 2020, a growth rate of 2,155% in just 6 years.
According to the data reported by the Intelligence Research Group in General Administration of Customs P.R.China, the Chinese bird’s nest market is growing at a CAGR of more than 30%, with an overall market size of about RMB 30 billion in 2019.
As for e-commerce, the sales of Tmall’s bird’s nest category will be approximately RMB 4.45 billion in 2020, representing a growth rate of 39% compared to the sales of RMB 3.19 billion in 2019, while bird’s nest will account for a maximum of 31.44% of tonic products in 2020.
China is undoubtedly the world’s largest consumer of bird’s nests, with four major consumer needs: pregnant women, health, gifts, and delicacies. With the rapid rise of the younger generation dedicated to “anti-aging,” bird’s nest has become a popular choice for young and old alike. Given China’s second and third child policy launch, it is expected that the market for bird’s nests will continue to expand.
Fuciphagus is ready to develop sales and distribution channels on a large scale by taking advantage of all favorable factors and combining its strengths and competitive advantages. In 2020, we had successfully opened up the Malaysian and Chinese markets with “Yan Wo Wang” and “Yan Yu Jia Ren” and succeeded in exporting the raw materials to China to cater to the local B2B and B2C markets. Hence the reason why we can boldly forecast to reach our performance target of RM65 million by 2025.
Our assurance stems from the advantages of a well-established technological production system and as a legitimate exporter, producing in-house formulated bird’s nest products and a comprehensive sales system in China. Moreover, using automated machines to reduce costs means that we can increase production at least twice as much as we would have done with the same amount of labor, further increasing profitability.
Promoting the proper information of bird’s nest nutrition and value
Promote a revolutionary breakthrough in the Malaysian bird’s nest industry
We hope to raise funds through the MyStartr crowdfunding platform with a target of RM1 million. The proportion of funds allocated is 40% for exploring new markets, developing new customers, and consumer knowledge dissemination efforts. Another 30% will be used to upgrade our existing facilities to increase production capacity to meet local and China market demand, while the remaining 30% will be used to cover the cost of registration fees for health supplement products.
Fuciphagus has evolved from a bird’s nest processing factory to an R&D, production, and sales company and is now Malaysia’s official one-stop bird’s nest exporter, wholesaler, and retailer. We will not just stop at producing and marketing our products, but we hope that Malaysia’s bird’s nest will become a world-class standard, which makes us the most sought-after bird’s nest exporter in the world.
To achieve this vision, we must enhance the quality of the bird’s nest and certify its health value!
In the journey towards this vision, we sincerely invite more Malaysians to join us to showcase the charm of the Malaysian bird’s nest to the world!
Fuciphagus Website: http://www.fuciphagus.com/
Fuciphagus 燕窝王 Website: https://yanwowang.com/
Fuciphagus 燕窝王 FB: https://www.facebook.com/YanWoWangMalaysia/
Fuciphagus 燕窝王 IG: https://www.instagram.com/yanwowang/
Fuciphagus 燕窝王 Whatsapp: Contact Us
For further enquiry
Please Contact Us
投资框架协议 (Term Sheet) & 投资配套 (Investment Packages)
Core Team
Founders' Pitch Deck
For further enquiry
Please Contact Us
For further enquiry
Please Contact Us
Fuciphagus大马第一批获得中国审批的燕窝出口商之一
我是莫志鸿 ,福喜發鉻(Fuciphagus Agritech)有限公司的董事兼首席执行官。
我在2006年创立Fuciphagus,以燕窝零售及养燕为主并在2011年转型设立燕窝清洗工厂。同年,我们积极筹备申请出口中国所需的资质。多番努力下,Fuciphagus终于在2014年成为了我国第一批获得中国审批的燕窝出口商之一。
Fuciphagus发起大众筹资旨在提升公司知名度、融资和开发客户,同时希望传承千年燕窝养生文化,向大众科普正确的燕窝营养知识及价值以便安心消费。长远来看,我们积极促进燕窝行业发掘更多科学临床研究和证明,进一步将燕窝产品归纳为保健品类以及药品类产品。
独创3D生物材料纳米加工技术荣获中美专利权
可能一些人不是很了解Fuciphagus,我们的业务不局限于燕窝清洗工厂,有别于同行及竞争对手,我们在科技研究方面投注最多资金,开发了酶法工艺、生产追溯系统、燕窝辨别系统、内部非破坏性NO2测试套件及各种相关科技。
随着新技术在传统燕窝领域的应用,完全颠覆了以往燕窝加工的模式:
- 达到自动化生产,可提高产量和降低成本,系统可复制;
- 可生产标准化原料及开发标准化产品,以达到高品质和高稳定产品的目标。
综上所述,我们利用了生物科技技术研发自动化生产系统,不但成功实现可稳定,即一致和重复的生产鲜炖燕窝原料,且保证燕窝有更长的条丝、没有黑点、没有微小羽毛、可100%安心食用。这些都可以随时在测试结果中展现,我们认为这是基本要求,但遗憾的是,并非所有的燕窝生产商或品牌都能做到这个标准。
现阶段我们主要提供给出口的B2B市场还有中国建立的自家品牌—燕语佳人;以“燕窝王”鲜炖燕窝主攻大马线上消费市场,并期待今年11月把一些产品出口到新加坡、台湾、日本及韩国。此外,我们有替其他品牌提供即食鲜炖燕窝代工生产的服务 (OEM)。
可喜可贺的是,我们的技术发明在去年8月和9月,先后获得美国和中国的专利权。所以我们要利用现有的技术,透过各种推广和营销渠道,快速加大并占有超过50%的市场份额,把过去投入的资源转化为盈收。
终极目标将燕窝注册归纳为保健及药品类产品
Fuciphagus的愿景是5年内成为世界级应用先进技术及科学证明的燕窝供应商,肩负着改变传统拥抱新技术,让每个人都可以吃上一口安心富有营养价值的燕窝的使命。
传统的燕窝产品仅被归纳为食品,但我们致力应用现代科学探索燕窝的营养价值,并以科研成果作为依托来推广最健康的燕窝食用方法。
唯有真凭实据才能让消费者看到燕窝真正的价值,进而获得各造认证和认同其营养价值,同时引导整个行业与消费市场走向健康的、专业的、科学的道路。
比方说,燕窝中的唾液酸含量已有许多科学证明有益于人脑中子系统及免疫系统,或可能对阿尔茨海默病及帕金森病等有抗病的功效。因此,我们的终极目标是将我们的燕窝产品升级,注册归纳为保健及药品类产品。
同步做市场和进行功效认证以加强产品公信力
当前全世界包括大马在内,很多燕窝产品只有产品验证,却没有功效认证。功效认证是一项艰难及需要大量金钱和时间的工作,比如其中最基本的过程就是把原料标准化问题。
鉴于Fuciphagus已掌握这项技术,标准化不成问题,这也是我们能够同步做市场和进行功效认证临床实验的关键因素。只要众筹达标,Fuciphagus与本地大学研究团队合作的临床实验,最快可以在今年第四季度展开工作。
与此同时,我们继续开发燕窝产品系列,细分产品分类并努力促成更大的燕窝产品消费市场,比如老年人,孕妇及小孩等市场,这也包括将燕窝与其他保健品结合,增加功效,让燕窝有更大的价值。
中国燕窝市场规模高达300亿人民币
大马出口燕窝存在23倍增长空间
最重要的是,一旦燕窝获认证及归纳为保健品,我们就可以从大马每年超过5000万令吉的燕窝市场,推进到超过31亿令吉的保健产品市场。
当然,燕窝市场并不局限于我国的数千万令吉市场。根据中国检验检疫科学研究院在《2020年度燕窝溯源报告》中,中国从大马进口的燕窝经于2014年的3.09吨发展到2020年的69.7吨,短短6年的增长率高达2155%。
中国海关网根据智研咨询时代数据显示,中国燕窝市场年复合增长率达到30%以上,2019年整体市场规模达到300亿人民币左右。
在电商方面,2020年天猫燕窝类目销售额约为44亿5000万人民币,相较2019年的销售额31亿9000万人民币,增长率达39%,而2020年燕窝占比滋补品最高达到31.44%。
毋庸置疑,中国是世界最大的燕窝消费国家,主要以孕妇、养生、送礼、美食四大消费需求,加上年轻一代「抗初老」消费群体快速崛起,燕窝成为老少咸宜的首选,加上中国推出二胎、三胎政策,预料燕窝市场空间将持续扩大。
Fuciphagus充分把握各种有利因素,结合自身条件和竞争优势,已经做好准备大规模性的开拓销售和分销渠道。
我们火力全开,已在2020年成功以“燕窝王”和“燕语佳人”开拓了大马和中国市场,也顺利将燕窝原料出口到中国应付当地的B2B和B2C市场。这也是为何我们能大胆预测在2025年达到6500万令吉的业绩目标。
我们的自信来自于完善的科技生产系统以及正规出口商的优势,有能力生产自家研发的燕窝产品,也在中国拥有完善的销售系统,加上利用机器自动化生产降低成本,即在同样人工基础上,我们至少能提升两倍的产量,进一步增加盈收。
普及正确的燕窝营养知识及价值
促进大马燕窝行业革命性突破
我们希望通过MyStartr众筹平台向大众筹集资金,目标是100万令吉,而资金分配比例是40%用于开拓新市场,发展新客户,进行消费知识普及工作;30%用于提升现有的设备以便提高生产量,应付本地及中国市场供应需求;30%用于支付保健品注册费用。
Fuciphagus从早期的燕窝加工工厂发展成研发、生产及销售的厂家,是大马正规兼一站式的燕窝出口商及批发零售专营企业。
我们不会止步于生产及营销产品,反观希望大马燕窝能跃身为世界顶级标准,成为各国争相进口的燕窝生产国。
达成这个宏愿的前提是提升燕窝的品质,认证燕窝的保健价值!在朝向这个宏愿的道路上,我们诚意邀请更多的大马人一起加入,发挥众志成城的力量向全世界展示大马燕窝的魅力!
Fuciphagus Website: http://www.fuciphagus.com/
燕窝王 Website: https://yanwowang.com/
燕窝王 FB: https://www.facebook.com/YanWoWangMalaysia/
燕窝王 IG: https://www.instagram.com/yanwowang/
燕窝王 Whatsapp: Contact Us
欲知更多详情,请联络我们
投资框架协议 (Term Sheet) & 投资配套 (Investment Packages)
团队("Core Team")
创办人募资简报 (“Founders' Pitch Deck”)
欲知更多详情,请联络我们
欲知更多详情,请联络我们
Packages
Investors
- Type of share: Ordinary Shares
- Number of share: 1,875
- Price per share: RM 0.80
- Product Pack worth RM 198 [Yan Wo Wang (5btl mix flavor) x 1 box]
Thank you for investing in us! You will also receive this share:
1,875 x RM 0.80 = RM 1,500
Additional rewards:
Investors
- Type of share: Ordinary Shares
- Number of share: 6,250
- Price per share: RM 0.80
- Product Pack worth RM 694 [Yan Wo Wang (5btl concentrate) x 1 box, Yan Wo Wang (5btl mix flavor) x 2 boxes]
Thank you for investing in us! You will also receive this share:
6,250 x RM 0.80 = RM 5,000
Additional rewards:
Investors
- Type of share: Ordinary Shares
- Number of share: 18,750
- Price per share: RM 0.80
- Product Pack worth RM 2,182 [Yan Wo Wang (5btl concentrate) x 4 boxes, Yan Wo Wang (5btl mix flavor) x 5 boxes]
Thank you for investing in us! You will also receive this share:
18,750 x RM 0.80 = RM 15,000
Additional rewards:
Investors
- Type of share: Ordinary Shares
- Number of shares: 31,250
- Price per share: RM 0.80
- Product Pack worth RM 3,968 [Yan Wo Wang (5btl concentrate) x 8 boxes, Yan Wo Wang (5btl mix flavor) x 8 boxes]
Thank you for investing in us! You will also receive this share:
31,250 x RM 0.80 = RM 25,000
Additional rewards:
Investors
- Type of share: Ordinary Shares
- Number of shares: 62,500
- Price per share: RM 0.80
- Product Pack worth RM 8,134 [Yan Wo Wang (5btl concentrate) x 16 boxes, Yan Wo Wang (5btl mix flavor) x 17 boxes]
Thank you for investing in us! You will also receive this share:
62,500 x RM 0.80 = RM 50,000
Additional rewards:
Investors
- Type of share: Ordinary Shares
- Number of share: 1,875
- Price per share: RM 0.80
- Product Pack worth RM 198 [Yan Wo Wang (5btl mix flavor) x 1 box]
- Early Bird Voucher worth RM 50
Early Bird Promotion
(Pledge before 25 July 2021 11.59pm)
Thank you for investing in us! You will also receive this share:
1,875 x RM 0.80 = RM 1,500
Additional rewards:
Investors
- Type of share: Ordinary Shares
- Number of share: 6,250
- Price per share: RM 0.80
- Product Pack worth RM 694 [Yan Wo Wang (5btl concentrate) x 1 box, Yan Wo Wang (5btl mix flavor) x 2 boxes]
- Early Bird Voucher worth RM 150 (RM 50 x 3)
Early Bird Promotion
(Pledge before 25 July 2021 11.59pm)
Thank you for investing in us! You will also receive this share:
6,250 x RM 0.80 = RM 5,000
Additional rewards:
Investors
- Type of share: Ordinary Shares
- Number of share: 18,750
- Price per share: RM 0.80
- Product Pack worth RM 2,182 [Yan Wo Wang (5btl concentrate) x 4 boxes, Yan Wo Wang (5btl mix flavor) x 5 boxes]
- Early Bird Voucher worth RM 400 (RM 50 x 8)
Early Bird Promotion
(Pledge before 25 July 2021 11.59pm)
Thank you for investing in us! You will also receive this share:
18,750 x RM 0.80 = RM 15,000
Additional rewards:
Investors
- Type of share: Ordinary Shares
- Number of shares: 31,250
- Price per share: RM 0.80
- Product Pack worth RM 3,968 [Yan Wo Wang (5btl concentrate) x 8 boxes, Yan Wo Wang (5btl mix flavor) x 8 boxes]
- Early Bird Voucher worth RM 500 (RM 50 x 10)
Early Bird Promotion
(Pledge before 25 July 2021 11.59pm)
Thank you for investing in us! You will also receive this share:
31,250 x RM 0.80 = RM 25,000
Additional rewards:
Investors
- Type of share: Ordinary Shares
- Number of shares: 62,500
- Price per share: RM 0.80
- Product Pack worth RM 8,134 [Yan Wo Wang (5btl concentrate) x 16 boxes, Yan Wo Wang (5btl mix flavor) x 17 boxes]
- Early Bird Voucher worth RM 1,000 (RM 50 x 20)
Early Bird Promotion
(Pledge before 25 July 2021 11.59pm)
Thank you for investing in us! You will also receive this share:
62,500 x RM 0.80 = RM 50,000
Additional rewards:
Investors
- Type of share: Ordinary Shares
- Number of shares: 250,000
- Price per share: RM 0.80
Thank you for investing in us!
You will also receive this share:
250,000 x RM 0.80 = RM 200,000
Additional rewards: customized
Disclaimer by Securities Commission
- No shares will be allotted or issued based on this document after six months from the closing of the offer period.
- This issue, offer or invitation for the offering is a proposal not requiring authorisation of the Securities Commission under section 212(8) of the CMSA 2007.
- This document has not been reviewed by the Securities Commission Malaysia. The Securities Commission does not recommend nor assumes responsibility for any information including any statement, opinion or report disclosed in relation to this fund raising exercise and makes no representation as to its accuracy or completeness. The Securities Commission expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information disclosed.
Please Login to post comments.